diphenylpyraline
Trade name: hispril
Diphenylpyraline is an antihistamine that prevents but does not reverse, responses mediated by histamine alone. Diphenylpyraline antagonizes most of the pharmacological effects of histamine, including urticaria and pruritus. Also, diphenylpyraline may exhibit anticholinergic actions (as do most of the antihistamines) and may thus provide a drying effect on the nasal mucosa. Antihistamines such as diphenylpyraline used in the treatment of allergy act by competing with histamine for H1-receptor sites on effector cells. This reduces the effects of histamine, leading to a temporary reduction of allergy symptoms. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Timeline
1960s
- Mar 15, 1960
Smith, Kline & French — First NDA Organization
- Mar 15, 1960
Smith, Kline & French — NDA Organization
Indications
Approved for
Mechanism of action
- Histamine H1 receptorANTAGONIST
HRH1 antagonist
Approval history
- approved—
Chemistry & pharmacology
SMILES
CN1CCC(OC(c2ccccc2)c2ccccc2)CC1- Mol. weight
- 281.4 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1492 ↗
- WikipediaDiphenylpyraline ↗
- NCATS33361OE3AV ↗
- ChEMBLCHEMBL444814 ↗
- ChEMBLCHEMBL1564 ↗
Also known as
- 1-methyl-4-hydroxypiperidine benzhydryl ether
- 1-methyl-4-hydroxypiperidine benzhydryl ether
- 1-methyl-4-piperidyl benzhydryl ether
- 1-methyl-4-piperidyl benzhydryl ether
- 4-(benzhydryloxy)-1-methylpiperidine
- 4-(benzhydryloxy)-1-methylpiperidine
- 4-(benzhydryloxy)-n-methylpiperidine
- 4-(benzhydryloxy)-n-methylpiperidine
- 4-diphenylmethoxy-1-methylpiperidine
- difenilpiralina
- difenilpiralina
- diphenpyraline
- diphenylpyralamine
- diphenylpyralamine
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline
- diphenylpyraline hcl
- diphenylpyraline hcl
- diphenylpyraline hcl
- diphenylpyraline hydrochloride
- diphenylpyraline hydrochloride
- diphenylpyraline hydrochloride
- diphenylpyraline hydrochloride
- diphenylpyraline hydrochloride
- diphenylpyraline maleate
- diphenylpyraline maleate (2:1)
- diphenylpyraline teoclate
- diphenylpyraline teoclate
- diphenylpyralinum
- diphenylpyralinum
- diphenylpyrilene
- hispril
- hispril
- hispril
- hispril
- hispril
- hispril
- histryl
- histryl
- histryl paed
- lergoban
- lergoban
- lergobine
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| GlaxoSmithKline | For profit | NDA2 | — |
| Smith, Kline & French | For profit | NDA | Mar 15, 1960 |